Sign In
Buy SRTS
$2.84
+0 (+0%)
At Close: Jun 03, 2026
Sensus Healthcare, Inc. (NASDAQ:SRTS) Given Average Recommendation of “Hold” by Analysts
05:24am, Sunday, 11'th Jan 2026
Sensus Healthcare, Inc. (NASDAQ: SRTS - Get Free Report) has earned a consensus rating of "Hold" from the five brokerages that are currently covering the stock, MarketBeat reports. One research analys
Sensus Healthcare to Hold Investor Meetings During JPM Week 2026 in San Francisco
04:30pm, Wednesday, 07'th Jan 2026
BOCA RATON, Fla.--(BUSINESS WIRE)--Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for
Sensus Healthcare Appoints Larry Biscotti to its Board of Directors
08:30am, Wednesday, 07'th Jan 2026
BOCA RATON, Fla.--(BUSINESS WIRE)--Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for
Sensus Healthcare (NASDAQ:SRTS) vs. Venus Concept (NASDAQ:VERO) Head-To-Head Comparison
02:14am, Sunday, 28'th Dec 2025
Sensus Healthcare (NASDAQ: SRTS - Get Free Report) and Venus Concept (NASDAQ: VERO - Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two
Sensus Healthcare Expands Role of President Michael Sardano to Include Chief Commercial Officer
08:00am, Friday, 14'th Nov 2025
BOCA RATON, Fla.--(BUSINESS WIRE)--Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for
Sensus Healthcare Appoints Eric Sachetta to its Board of Directors
08:00am, Wednesday, 12'th Nov 2025
BOCA RATON, Fla.--(BUSINESS WIRE)--Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for
Sensus Healthcare, Inc. (SRTS) Q3 2025 Earnings Call Transcript
09:46pm, Thursday, 06'th Nov 2025
Sensus Healthcare, Inc. ( SRTS ) Q3 2025 Earnings Call November 6, 2025 4:30 PM EST Company Participants Joseph Sardano - Co-Founder, Chairman & CEO Michael Sardano - President, General Counsel, Corpo
Sensus Healthcare, Inc. (SRTS) Reports Q3 Loss, Tops Revenue Estimates
07:06pm, Thursday, 06'th Nov 2025
Sensus Healthcare, Inc. (SRTS) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of a loss of $0.12. This compares to earnings of $0.07 per share a year ago.
Sensus Healthcare Reports Third Quarter 2025 Financial Results
04:05pm, Thursday, 06'th Nov 2025
BOCA RATON, Fla.--(BUSINESS WIRE)--Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective non-invasive, minimally-invasive and cost-effective treatments for
Sensus Healthcare Named to TIME's America's Growth Leaders of 2026
08:00am, Thursday, 06'th Nov 2025
BOCA RATON, Fla.--(BUSINESS WIRE)--Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for
CMS Establishes Coding Validating Sensus SRT for Treating Non-Melanoma Skin Cancer
08:00am, Tuesday, 04'th Nov 2025
BOCA RATON, Fla.--(BUSINESS WIRE)--Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for
Sensus Healthcare Announces the Passing of Director Bill McCall
08:00am, Friday, 31'st Oct 2025
BOCA RATON, Fla.--(BUSINESS WIRE)--Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for
Sensus Healthcare to Report Third Quarter 2025 Financial Results and Hold Business Update Conference Call on November 6
08:00am, Thursday, 23'rd Oct 2025
BOCA RATON, Fla.--(BUSINESS WIRE)---- $SRTS--Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective trea
Sensus Healthcare, Inc. (SRTS) Falls More Steeply Than Broader Market: What Investors Need to Know
07:16pm, Thursday, 16'th Oct 2025
Sensus Healthcare, Inc. (SRTS) closed the most recent trading day at $3.31, moving 4.06% from the previous trading session.
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Sensus (SRTS) To Contact Him Directly To Discuss Their Options If you purchased or acqui
